Breed of mice created for leukemia study

August 22, 2006

A study by U.S. cancer scientists at Ohio State University shows a new strain of mice offers the first real animal model for an incurable chronic leukemia.

The mouse, called the TCL-1 transgenic mouse, develops a malignancy that closely mimics chronic lymphocytic leukemia, or CLL. The lack of such an animal model has previously hampered the development of treatments for CLL, as well as research into its causes and the changes that drive drug resistance.

"This mouse strain shares many of the molecular and genetic features of human CLL, responds to drugs typically used to treat the disease and develops drug resistance that renders treatment ineffective, as often happens in CLL patients," said principal investigator John Byrd, a professor of internal medicine.

Byrd is a specialist in CLL at Ohio State University's Arthur James Cancer Hospital and Richard Solove Research Institute.

"The strain should be extremely valuable for the development and testing of both conventional drugs and those aimed at molecular targets for CLL," he said.

The findings are published in the Aug. 15 issue of the journal Blood.

Copyright 2006 by United Press International

Explore further: Gene shut-down may offer early warning of chronic leukemia

Related Stories

Recommended for you

Amazon deforestation leaps 16 percent in 2015

November 28, 2015

Illegal logging and clearing of Brazil's Amazon rainforest increased 16 percent in the last year, the government said, in a setback to the aim of stopping destruction of the world's greatest forest by 2030.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.